| Code | 6854A | ||||||||||
| MA number | 09/0236/07-S | ||||||||||
| Product Form: | tbl ent 20x20 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.06.2007 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_OTC_Nolpaza 20 mg_tbl ent_02_2024.pdf
|
| PIL: |
PIL_Rx_Nolpaza 20 mg_tbl ent_02_2024.pdf
|
| SPC: |
SPC_OTC_Nolpaza 20 mg_tbl ent_02_2024.pdf
|
| SPC: |
SPC_Rx_Nolpaza 20 mg_tbl ent_02_2024.pdf
|
| Safety feature | Yes |
| Data update: | 29.06.2018 |
